Youngevity (NASDAQ:YGYI) Reshapes Board To Be Majority Independent Directors.

Youngevity International, Inc. (Nasdaq: YGYI) today announced that effective February 11, 2020, in order to maintain compliance with the corporate governance requirements of The Nasdaq Capital Market, and specifically Listing Rule 5605(b) which provides that a listed company’s board of directors shall be comprised of a majority of independent directors, Michelle Wallach and Richard Renton, two non-independent members of the Board of Directors of Youngevity International, Inc. (the “Company”), resigned as members of the Board of Directors of the Company.  Steve Wallach, CEO of Youngevity International will continue as a board member and will remain the Chairman of the Board and Dave Briskie, President and CFO of Youngevity will also remain on the Board of Directors.